Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» New cancer drugs "vastly overestimated", says contrarian analyst
New cancer drugs "vastly overestimated", says contrarian analyst
New cancer drugs "vastly overestimated", says contrarian analyst
Submitted by
admin
on March 31, 2015 - 12:46pm
Source:
Yahoo/Reuters
News Tags:
cancer
PD-1 inhibitors
PDL-1 inhibitors
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Headline:
New cancer drugs "vastly overestimated", says contrarian analyst
Do Not Allow Advertisers to Use My Personal information
